These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30020772)

  • 1. Pharmacology and Therapeutic Potential of the 5-HT
    Blattner KM; Canney DJ; Pippin DA; Blass BE
    ACS Chem Neurosci; 2019 Jan; 10(1):89-119. PubMed ID: 30020772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-hydroxytryptamine (5-HT) receptor ligands.
    Kitson SL
    Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical update on the potential for serotonin 5-HT
    Kucwaj-Brysz K; Baltrukevich H; Czarnota K; Handzlik J
    Bioorg Med Chem Lett; 2021 Oct; 49():128275. PubMed ID: 34311086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of serotonin 5-HT
    Thirumaran SL; Lepailleur A; Rochais C
    Eur J Med Chem; 2019 Dec; 183():111705. PubMed ID: 31581003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis.
    Wang YQ; Lin WW; Wu N; Wang SY; Chen MZ; Lin ZH; Xie XQ; Feng ZW
    Acta Pharmacol Sin; 2019 Sep; 40(9):1138-1156. PubMed ID: 30814658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latest advances towards the discovery of 5-HT(7) receptor ligands.
    Pittala V; Pittala D
    Mini Rev Med Chem; 2011 Nov; 11(13):1108-21. PubMed ID: 22353220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective agonists for serotonin 7 (5-HT7) receptor and their applications in preclinical models: an overview.
    Di Pilato P; Niso M; Adriani W; Romano E; Travaglini D; Berardi F; Colabufo NA; Perrone R; Laviola G; Lacivita E; Leopoldo M
    Rev Neurosci; 2014; 25(3):401-15. PubMed ID: 24622785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Membranes of Human SH-SY5Y Neuroblastoma Cells Express Serotonin 5-HT
    Tempio A; Niso M; Laera L; Trisolini L; Favia M; Ciranna L; Marzulli D; Petrosillo G; Pierri CL; Lacivita E; Leopoldo M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation.
    Dukat M; Choi YN; Teitler M; Du Pre A; Herrick-Davis K; Smith C; Glennon RA
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1599-603. PubMed ID: 11412989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.
    Crider JY; Williams GW; Drace CD; Katoli P; Senchyna M; Sharif NA
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4837-44. PubMed ID: 14578406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
    López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
    Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
    Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
    Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
    Krobert KA; Bach T; Syversveen T; Kvingedal AM; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):620-32. PubMed ID: 11414657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacophore models for metabotropic 5-HT receptor ligands.
    Bojarski AJ
    Curr Top Med Chem; 2006; 6(18):2005-26. PubMed ID: 17017971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms.
    Lovenberg TW; Baron BM; de Lecea L; Miller JD; Prosser RA; Rea MA; Foye PE; Racke M; Slone AL; Siegel BW
    Neuron; 1993 Sep; 11(3):449-58. PubMed ID: 8398139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signalling properties and pharmacology of a 5-HT7 -type serotonin receptor from Tribolium castaneum.
    Vleugels R; Lenaerts C; Vanden Broeck J; Verlinden H
    Insect Mol Biol; 2014 Apr; 23(2):230-43. PubMed ID: 24330075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2a-[4-(Tetrahydropyridoindol-2-yl)butyl]tetrahydrobenzindole derivatives: new selective antagonists of the 5-hydroxytryptamine7 receptor.
    Kikuchi C; Ando T; Watanabe T; Nagaso H; Okuno M; Hiranuma T; Koyama M
    J Med Chem; 2002 May; 45(11):2197-206. PubMed ID: 12014957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-HT-7 receptor ligands on memory and cognition.
    Zareifopoulos N; Papatheodoropoulos C
    Neurobiol Learn Mem; 2016 Dec; 136():204-209. PubMed ID: 27780766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT7 receptors as a new target for prostate cancer physiopathology and treatment: an experimental study on PC-3 cells and FFPE tissues.
    Cinar I; Sirin B; Halici Z; Palabiyik-Yucelik SS; Akpinar E; Cadirci E
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1205-1213. PubMed ID: 33528589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.